Securities Fraud Class Action Filed Against O-I Glass, Inc.: Glancy Prongay Wolke & Rotter LLP Announces Lead Plaintiff Deadline
LOS ANGELES--( BUSINESS WIRE)--A securities fraud class action lawsuit has been filed against O-I Glass, Inc. ("O-I Glass" or the "Company") (NYSE: OI) on behalf of investors who purchased or otherwise acquired the Company's securities between March 14, 2025 and July 28, 2026, inclusive. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced the filing. The O-I Glass, Inc. case, Bryan v. O-I Glass, Inc. et al., was filed on October 29, 2026 in the U.S. District Court Ohio Northern District Court (Case No. 3:26-cv-02849). O-I Glass, Inc. investors have until December 28, 2026 to file a lead plaintiff motion.
Investors who suffered losses on O-I Glass, Inc. investments can inquire about the O-I Glass, Inc. class action to learn about potentially pursuing claims under the federal securities laws before the December 28, 2026 lead plaintiff deadline.
The O-I Glass, Inc. case at a glance
What happened?
On July 28, 2026, O-I Glass announced its second quarter 2026 financial results, substantially reducing its 2026 adjusted EBITDA and free cash flow guidance and realigning its 2027 Investor Day financial targets.
On this news, O-I Glass stock fell $1.36 or 15.01%, to close at $7.70 on July 29, 2026.
What does the O-I Glass, Inc. lawsuit allege?
The O-I Glass, Inc. class action lawsuit alleges that, throughout the class period, defendants made materially false and/or misleading statements and failed to disclose material adverse facts about O-I Glass, Inc.'s business, operations, and prospects. Specifically, the complaint alleges defendants failed to disclose to investors that: (1) the true state of O-I Glass' Fit to Win program, including the delay in achieving its targeted cost savings, higher than expected expenses, operational disruptions that materially offset Fit to Win benefits; (2) continued competitive and energy-cost pressures affecting its European operations; and (3) as a result, defendants' positive statements about O-I Glass, Inc.'s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Investors who purchased or otherwise acquired O-I Glass, Inc. securities during the class period may move the Court no later than December 28, 2026 to request appointment as lead plaintiff in this putative class action lawsuit.
"The complaint against O-I Glass, Inc. alleges, among other things, that the Company failed to disclose that the true state of O-I Glass' Fit to Win program, including the delay in achieving its targeted cost savings, higher than expected expenses, operational disruptions that materially offset Fit to Win benefits. Investors who purchased during the class period may be able to recover their losses in the class action, and any investor interested in serving as lead plaintiff should note the December 28, 2026 deadline," said Charles H. Linehan, Partner at Glancy Prongay Wolke & Rotter LLP.
What's the next step?
Glancy Prongay Wolke & Rotter LLP is a leading national shareholder rights law firm, ready to assist O-I Glass, Inc. investors in potentially pursuing claims to recover their losses. To learn more about the O-I Glass, Inc. lawsuit or your rights, visit the O-I Glass, Inc. case page, email shareholders@glancylaw.com, or call 310-201-9150 (toll-free: 888-773-9224).
If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.
To be a member of the O-I Glass, Inc. class, you need not take any action at this time. You may retain counsel of your choice or take no action and remain an absent class member. No class has been certified yet in the O-I Glass, Inc. case.
Frequently Asked Questions
Who is eligible? Investors who purchased or otherwise acquired O-I Glass, Inc. securities between March 14, 2025 and July 28, 2026 and suffered losses may be members of the proposed class in the O-I Glass, Inc. securities lawsuit.
Where was the O-I Glass, Inc. lawsuit filed? The O-I Glass, Inc. class action, Bryan v. O-I Glass, Inc. et al., was filed on October 29, 2026 in the U.S. District Court Ohio Northern District Court as Case No. 3:26-cv-02849.
What is a lead plaintiff? In the O-I Glass, Inc. class action, the lead plaintiff is the investor, or group of investors, that the court appoints to represent all class members and oversee the case. Under the Private Securities Litigation Reform Act, courts generally presume the movant with the largest financial interest is the most adequate lead plaintiff.
Do I need to act to be part of the O-I Glass, Inc. class? No. O-I Glass, Inc. investors need not take any action at this time to be class members, and their ability to share in any future recovery does not depend on serving as lead plaintiff.
Does it cost anything to contact Glancy or participate in this action? Glancy represents O-I Glass, Inc. investors on a contingency fee basis, so investors pay no attorneys' fees out of pocket. Any attorneys' fees and litigation expenses are paid only from a recovery, if one is obtained, and are subject to court approval.
Why work with Glancy on the O-I Glass, Inc. lawsuit? Glancy Prongay Wolke & Rotter LLP is a premier law firm with decades of experience representing investors and consumers in securities litigation and other complex class action litigation. Contact Glancy about the O-I Glass, Inc. shareholder lawsuit. Prior results do not guarantee a similar outcome.
About Glancy Prongay Wolke & Rotter LLP
Glancy was named one of Law360's Securities Groups of the Year and ranked second in total investor recoveries by ISS Securities Class Action Services in 2025.
Glancy's successes have been widely covered by leading news and industry publications, including The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron's, Investor's Business Daily, Forbes, and Money.
Prior results do not guarantee a similar outcome.
Related links
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.